These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31600950)
41. Spectral and biological evaluation of a synthetic antimicrobial peptide derived from 1-aminocyclohexane carboxylic acid. Abercrombie JJ; Leung KP; Chai H; Hicks RP Bioorg Med Chem; 2015 Mar; 23(6):1341-7. PubMed ID: 25684423 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of 4-hydroxycoumarin heteroarylhybrids as potential antimicrobial agents. Siddiqui ZN; N MM; Ahmad A; Khan AU Arch Pharm (Weinheim); 2011 Jun; 344(6):394-401. PubMed ID: 21647940 [TBL] [Abstract][Full Text] [Related]
43. Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives. Giles D; Roopa K; Sheeba FR; Gurubasavarajaswamy PM; Divakar G; Vidhya T Eur J Med Chem; 2012 Dec; 58():478-84. PubMed ID: 23159805 [TBL] [Abstract][Full Text] [Related]
44. Design and Evaluation of Novel Antimicrobial and Anticancer Agents Among Tetrazolo[1,5-c]quinazoline-5-thione S-Derivatives. Antypenko LM; Kovalenko SI; Antypenko OM; Katsev AM; Achkasova OM Sci Pharm; 2013; 81(1):15-42. PubMed ID: 23641327 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of some new coumarin derivatives as potential antimicrobial agents. Singh LK; Priyanka ; Singh V; Katiyar D Med Chem; 2015; 11(2):128-34. PubMed ID: 25181986 [TBL] [Abstract][Full Text] [Related]
46. Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives. Nasab RR; Mansourian M; Hassanzadeh F Res Pharm Sci; 2018 Jun; 13(3):213-221. PubMed ID: 29853931 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives. Shi LP; Jiang KM; Jiang JJ; Jin Y; Tao YH; Li K; Wang XH; Lin J Bioorg Med Chem Lett; 2013 Nov; 23(21):5958-63. PubMed ID: 24044873 [TBL] [Abstract][Full Text] [Related]
48. In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus. Hincapié O; Giraldo P; Orduz S Antonie Van Leeuwenhoek; 2018 Oct; 111(10):1871-1882. PubMed ID: 29626331 [TBL] [Abstract][Full Text] [Related]
49. Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs. Shankar B; Jalapathi P; Saikrishna B; Perugu S; Manga V Chem Cent J; 2018 Jan; 12(1):1. PubMed ID: 29318401 [TBL] [Abstract][Full Text] [Related]
50. Isolation and determination of four potential antimicrobial components from Xu LQ; Zeng JW; Jiang CH; Wang H; Li YZ; Wen WH; Li JH; Wang F; Ting WJ; Sun ZY; Huang CY Int J Med Sci; 2017; 14(13):1368-1374. PubMed ID: 29200950 [No Abstract] [Full Text] [Related]
51. C-3 Substituted Lawsonemonoximates of Holmium(III): Synthesis, Characterization, and Antimicrobial Activity. Jagtap SB; Joshi SG; Litake GM; Ghole VS; Kulkarni BA Met Based Drugs; 2000; 7(3):147-50. PubMed ID: 18475938 [TBL] [Abstract][Full Text] [Related]
52. Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones. Patil BS; Krishnamurthy G; Bhojya Naik HS; Latthe PR; Ghate M Eur J Med Chem; 2010 Aug; 45(8):3329-34. PubMed ID: 20457477 [TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and antimicrobial activity of novel benzothiazole analogs. Singh MK; Tilak R; Nath G; Awasthi SK; Agarwal A Eur J Med Chem; 2013 May; 63():635-44. PubMed ID: 23567952 [TBL] [Abstract][Full Text] [Related]
54. One-Pot Three-Component Synthesis and Molecular Docking of Some Novel 2-Thiazolyl Pyridines as Potent Antimicrobial Agents. Abdelrazek FM; Gomha SM; Shaaban MEB; Rabee KA; El-Shemy HN; Abdallah AM; Metz P Mini Rev Med Chem; 2019; 19(6):527-538. PubMed ID: 30360710 [TBL] [Abstract][Full Text] [Related]
55. Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies. Al-Adhreai A; ALSaeedy M; Alrabie A; Al-Qadsy I; Dawbaa S; Alaizeri ZM; Alhadlaq HA; Al-Kubati A; Ahamed M; Farooqui M Heliyon; 2022 Jun; 8(6):e09746. PubMed ID: 35800717 [TBL] [Abstract][Full Text] [Related]
56. Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination. Wang YT; Shi TQ; Fu J; Zhu HL Eur J Med Chem; 2019 Jun; 171():209-220. PubMed ID: 30925337 [TBL] [Abstract][Full Text] [Related]
57. Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activities. Küçükbay H; Durmaz R; Güven M; Günal S Arzneimittelforschung; 2001; 51(5):420-4. PubMed ID: 11413744 [TBL] [Abstract][Full Text] [Related]
58. Biological evaluation, docking and molecular dynamic simulation of some novel diaryl urea derivatives bearing quinoxalindione moiety. Sadeghian-Rizi S; Khodarahmi GA; Sakhteman A; Jahanian-Najafabadi A; Rostami M; Mirzaei M; Hassanzadeh F Res Pharm Sci; 2017 Dec; 12(6):500-509. PubMed ID: 29204178 [TBL] [Abstract][Full Text] [Related]
59. In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents. Abuelizz HA; El-Dib RA; Marzouk M; Al-Salahi R Microb Pathog; 2018 Apr; 117():60-67. PubMed ID: 29432912 [TBL] [Abstract][Full Text] [Related]
60. New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation. Barbuceanu SF; Saramet G; Almajan GL; Draghici C; Barbuceanu F; Bancescu G Eur J Med Chem; 2012 Mar; 49():417-23. PubMed ID: 22309915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]